https://scholars.lib.ntu.edu.tw/handle/123456789/633603
標題: | Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer | 作者: | WEI-WU CHEN Hsiao, Wen Dai, Ming-Shen CHING-HUNG LIN DWANG-YING CHANG I-CHUN CHEN MING-YANG WANG Chang, Shu-Han Huang, Shu-Min ANN-LII CHENG Wu, Ko-Wen Tan, Kien Thiam YEN-SHEN LU |
關鍵字: | Breast cancer; Cell-free tumor DNA; Endocrine receptor; Liquid biopsy | 公開日期: | 21-六月-2023 | 來源出版物: | Breast cancer research and treatment | 摘要: | How to factor both tumor burden and oncogenic genomic mutations as variables to predict the outcome of endocrine-based therapy (ET) in ER-positive/HER2-negative metastatic breast cancer patients (MBC) remains to be explored. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/633603 | ISSN: | 01676806 | DOI: | 10.1007/s10549-023-06967-3 |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。